| 15
Reconciliation of GAAP Net Income to Non-GAAP Net Income
(Unaudited; in thousands except per share amounts)
Note: Certain per share impacts may not sum to totals due to rounding.
GAAP net income $ 112,089 $ (17,678) $ 94,411 $ 1.62 $ 82,629 $ (8,113) $ 74,516 $ 1.29 Non-GAAP adjustments: Cost of Sales
Amortization of intangibles 47,795 (11,492) 36,303 0.62 42,154 (10,335) 31,819 0.55 Corporate restructuring (a) 448 (108) 340 0.01 — — — — Inventory mark-up related to acquisitions 2,069 (497) 1,572 0.03 — — — — Operating Expenses
Contingent consideration expense 1,704 (47) 1,657 0.03 4,611 14 4,625 0.08 Impairment charges 270 — 270 0.00 2,219 (318) 1,901 0.03 Amortization of intangibles 8,293 (1,998) 6,295 0.11 6,300 (1,558) 4,742 0.08 Performance-based share-based compensation (b) 8,526 (1,121) 7,405 0.13 5,506 (546) 4,960 0.09 Corporate transformation and restructuring (c) 19,365 (4,646) 14,719 0.25 23,757 (5,516) 18,241 0.32 Acquisition-related 5,286 (1,269) 4,017 0.07 2,114 (517) 1,597 0.03 Medical Device Regulation expenses (d) 11,822 (2,838) 8,984 0.15 12,933 (3,166) 9,767 0.17 Other (e) (1,268) 304 (964) (0.02) 7,966 (1,893) 6,073 0.11 Other (Income) Expense
Amortization of long-term debt issuance costs 1,639 (393) 1,246 0.02 604 (148) 456 0.01 Gain (loss) on disposal of business unit (431) — (431) (0.01) 1,407 (29) 1,378 0.02 Tax expense related to restructuring (f) — — — — — (4,324) (4,324) (0.07) Non-GAAP net income $ 217,607 $ (41,783) $ 175,824 $ 3.01 $ 192,200 $ (36,449) $ 155,751 $ 2.70 Diluted shares 58,356 57,671
Pre-Tax Tax Impact After-Tax Per Share Impact Pre-Tax Tax Impact After-Tax Per Share Impact
Year Ended Year Ended
December 31, 2023 December 31, 2022 |